Psychedelics: The Eight Capital Primer
Eight Capital recently produced a primer on the psychedelic sector saying that the companies are “poised to fill a growing
Read more
Small Pharma Inc
Small Pharma: Canaccord Initiates Coverage With $1.00 Price Target
Canaccord Genuity recently initiated coverage on Small Pharma Inc (TSXV: DMT), a company that is developing the psychedelic compounds DMT
Read more